The Testosterone Replacement
Therapy Products Liability Litigation, or MDL 2545, began with less than 50 Androgel claims and has now amassed over 1,000 cases regarding injuries allegedly sustained from various Low T drugs.
He was appointed to serve on the Plaintiff's Steering Committee for In re: Vioxx Product Liability Litigation, MDL 1657 (E.D. La) and In Re: Testosterone Replacement
Therapy Products Liability Litigation, MDL 2545 (N.D. Ill.).
Not exact matches
Victory for pharmaceutical giants Pfizer in a
product liability litigation about alleged cardiovascular injuries associated with testosterone replacement
therapies
It may well be that the coming (and to some extent existing) revolution in genetically individualized medical
therapy will require changes in how drugs are evaluated, labeled, etc., but this is a singularity - driven issue that needs to be addressed by the policy branches of our government, and not haphazardly in
product liability litigation.